Cancer treatments using immune system come with a cost

February 20, 2018

From the January/February 2018 issue of HealthCare Business News magazine

As successful cancer fighting progress continues with cell re-programming, the price tag will begin to drop to more reasonable levels. Hope comes with a price, but for those experiencing complete remission from innovation, it’s worth it.

About the author: Thom Wellington is the CEO and a stockholder in Infection Control University.

Back to HCB News



You Must Be Logged In To Post A Comment Sign In If you've already created an account, use your email address and password to sign in using the form below. Login Problems: Click here if you are having login issues. Email address: Password: Forgot your password? Login Problems? View our Legal Notice and Privacy Notice Register Registration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now!